5-[(1R)-2-[(5,6-Diethyl-2,3-dihydro-1H-inden-2-yl)amino]-1-hydroxyethyl]-8-hydroxyquinolin-2(1H)-one

CAS : 312753-06-3

Ref. 3D-FI24565

Informations sur le produit

• Nom: 5-[(1R)-2-[(5,6-Diethyl-2,3-dihydro-1H-inden-2-yl)amino]-1-hydroxyethyl]-8-hydroxyquinolin-2(1H)-one
• Synonymes: 5-[(1R)-2-[(5,6-Diethyl-2,3-dihydro-1H-inden-2-yl)amino]-1-hydroxyethyl]-8-hydroxy-2(1H)-quinolinoneQAB 149Indacaterol, 2(1H)-Quinolinone, 5-[(1R)-2-[(5,6-diethyl-2,3-dihydro-1H-inden-2-yl)amino]-1-hydroxyethyl]-8-hydroxy-, 5-[(1R)-2-[(5,6-Diethyl-2,3-dihydro-1H-inden-2-yl)amino]-1-hydroxyethyl]-8-hydroxy-2(1H)-quinolinone, 5-{2-[(5,6-diethyl-2,3-dihydro-1H-inden-2-yl)amino]-1-hydroxyethyl}-8-hydroxyquinolin-2(1H)-one, Indacaterol, Qab-149
• CAS: 312753-06-3

Description

Indacaterol is a pharmacological agent that is used to treat asthma. This drug works by relaxing the smooth muscles in the airways, which leads to bronchodilation and improved airflow. It has been shown to be safe and effective for use in patients with asthma who have not responded well to previous treatments. Indacaterol is known as an agonist of beta-adrenergic receptors, which are found on the surface of airway smooth muscle cells. When these receptors are activated, they trigger a sequence of reactions that result in the opening of potassium channels, leading to membrane hyperpolarization and relaxation of the muscle. In vitro experiments have shown that indacaterol binds specifically with DNA from pluripotent cells, such as stem cells and neural progenitor cells. It also has electrochemical impedance spectroscopy properties, which can be used to measure its chemical stability. The most common symptoms associated with indacaterol treatment are dyspnea (shortness of

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 392.49 g/mol
• Formule: C₂₄H₂₈N₂O₃
• Degré de pureté: Min. 95%